Expression of osteoclast differentiation factor in rheumatoid arthritis
Open Access
- 1 November 2000
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (11) , 2523-2530
- https://doi.org/10.1002/1529-0131(200011)43:11<2523::aid-anr20>3.0.co;2-z
Abstract
Objective To analyze the expression pattern of osteoclast differentiation factor (ODF) and its contribution to osteoclastogenesis in rheumatoid arthritis (RA). Methods The expression of ODF was analyzed by reverse transcriptase–polymerase chain reaction (RT‐PCR) in RA synovial fibroblasts (RASF) isolated from 7 RA patients and in normal skin fibroblasts. Using RNA probes specific for ODF, in situ hybridization was performed. Immunohistochemical double labeling for CD68 was applied to characterize the ODF‐expressing cells. ODF protein and messenger RNA (mRNA) expression by RASF with or without 1,25(OH)2D3 was studied by Western blot analysis and quantitative real‐time PCR. In addition, we performed coculture experiments with RASF and normal peripheral blood mononuclear cells with or without 1,25(OH)2D3. Results By RT‐PCR, ODF mRNA expression was found in all RASF investigated, but not in normal skin fibroblasts. In situ hybridization revealed that in RA synovial tissues, ODF mRNA was expressed mainly in the lining layer and at sites where synovium was attached to bone. Immunohistochemical double labeling demonstrated ODF mRNA expression mainly in CD68− fibroblast‐like synoviocytes and CD68+ multinucleated osteoclast‐like cells. By Western blotting, all RASF expressed ODF protein. However, different levels of ODF expression were found in the RASF from different patients. Interestingly, RASF expressing higher levels of ODF induced a larger number of osteoclast‐like cells than did RASF expressing only low levels of ODF. Although 1,25(OH)2D3 did not alter the levels of ODF expression in RASF on either Western blot or quantitative real‐time PCR, osteoclastogenesis required the presence of 1,25(OH)2D3. Conclusion The present results suggest that activated RASF, by expressing ODF, play an important role in rheumatoid bone destruction. Moreover, the data provide evidence that RASF not only activate osteoclasts, but also contribute directly to osteoclastogenesis.Keywords
This publication has 24 references indexed in Scilit:
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- Activated T Lymphocytes Support Osteoclast Formation in VitroBiochemical and Biophysical Research Communications, 1999
- Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)Journal of Biological Chemistry, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- A New Mechanism of Bone Destruction in Rheumatoid Arthritis: Synovial Fibroblasts Induce OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1996
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formationJournal of Bone and Mineral Research, 1996
- CONSTITUTIVE mRNA AND PROTEIN PRODUCTION OF MACROPHAGE COLONY-STIMULATING FACTOR BUT NOT OF OTHER CYTOKINES BY SYNOVIAL FIBROBLASTS FROM RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTSRheumatology, 1994
- Collagenase Synthesis of Rheumatoid Arthritis Synoviocytes: Dose-dependent Stimulation by Substance P and CapsaicinScandinavian Journal of Rheumatology, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988